Jefferies Group’s ESSA Pharma EPIX Stock Holding History

Jefferies Group’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62,502	Closed	-$500K	–	1731
2021 Q3	$500K	Buy	+62,502	New	+$994K	﹤0.01%	1225

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jefferies Group's EPIX Position: Q4 2021 in Review

Jefferies Group sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 62,502 shares — an estimated $500K sold.

Jefferies Group first reported a position in EPIX in Q3 2021 and held it in 1 quarter. The position peaked at $500K in Q3 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

Jefferies Group reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
Jefferies Group sold 62,502 ESSA Pharma shares in Q4 2021, an estimated $500K.
Jefferies Group first reported a position in ESSA Pharma in Q3 2021 and held it in 1 quarter.
Jefferies Group's ESSA Pharma position peaked at $500K in Q3 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.